BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 16583177)

  • 1. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
    Ahmet I; Lakatta EG; Talan MI
    Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
    Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
    Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
    Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.
    Ahmet I; Morrell C; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2009 Oct; 331(1):178-85. PubMed ID: 19587314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoterol enantiomers do not possess beneficial therapeutic properties of their racemic mixture in the rat model of post myocardial infarction dilated cardiomyopathy.
    Ahmet I; Turner T; Lakatta EG; Talan MI
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):101-8. PubMed ID: 22328006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cardiac events caused by surgical stress in aged rats: simultaneously activating β2-adrenoceptor and inhibiting β1-adrenoceptor.
    Sun Y; Wang Y; Zhang L; Xu C; Liu Y; Kang S; Yan C; Li D; Sun H
    Stress; 2014 Jul; 17(4):373-81. PubMed ID: 24754893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.
    Xydas S; Kherani AR; Chang JS; Klotz S; Hay I; Mutrie CJ; Moss GW; Gu A; Schulman AR; Gao D; Hu D; Wu EX; Wei C; Oz MC; Wang J
    J Pharmacol Exp Ther; 2006 May; 317(2):553-61. PubMed ID: 16421285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of long-term beta-blockade in experimental chronic aortic regurgitation.
    Plante E; Lachance D; Champetier S; Drolet MC; Roussel E; Arsenault M; Couet J
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1888-95. PubMed ID: 18296565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
    Omerovic E; Bollano E; Soussi B; Waagstein F
    Eur J Heart Fail; 2003 Dec; 5(6):725-32. PubMed ID: 14675850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.
    Rinaldi B; Donniacuo M; Sodano L; Gritti G; Martuscelli E; Orlandi A; Rafaniello C; Rossi F; Calzetta L; Capuano A; Matera MG
    Br J Pharmacol; 2015 Jul; 172(14):3627-37. PubMed ID: 25825265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
    Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M; Mackiewicz U
    Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion.
    Latini R; Masson S; Jeremic G; Luvarà G; Fiordaliso F; Calvillo L; Bernasconi R; Torri M; Rondelli I; Razzetti R; Bongrani S
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):601-8. PubMed ID: 9554811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation.
    Pat B; Killingsworth C; Denney T; Zheng J; Powell P; Tillson M; Dillon AR; Dell'Italia LJ
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2321-7. PubMed ID: 18849331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
    Yaoita H; Sakabe A; Maehara K; Maruyama Y
    Circulation; 2002 Feb; 105(8):975-80. PubMed ID: 11864928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of beta-blockade in experimental chronic aortic regurgitation.
    Plante E; Lachance D; Gaudreau M; Drolet MC; Roussel E; Arsenault M; Couet J
    Circulation; 2004 Sep; 110(11):1477-83. PubMed ID: 15353507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion.
    Masson S; Masseroli M; Fiordaliso F; Calvillo L; D'Aquila S; Bernasconi R; Garrido G; Torri M; Razzetti R; Bongrani S; Latini R
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):321-6. PubMed ID: 10470987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.